000			02388cam a2200349 a 4500
003			EG-GiCUC
005			20250223031651.0
008			170218s2016 ua o f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.09.13.M.Sc.2016.Na.U
100	0		_aNashwa Osama Mohamed
245	1	4	_aThe use of botulinum toxin injection in management of myofascial pain dysfunction / _cNashwa Osama Mohamed ; Supervised Sayed Mahmoud Attia , Amany Hussein Nemat , Mohamed Faramawy
246	1	5	_aاستخدام البوتكس فى علاج متلازمة الاختلال الوظيفى لعضلات الوجه
260			_aCairo : _bNashwa Osama Mohamed , _c2016
300			_a98 P. : _bphotographs ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Oral and Dental Medicine - Department of Oral and Maxillofacial Surgery
520			_aThe aim of this study was to evaluate the short-term effect of the botulinum toxin type A injection for the treatment of myofascial pain dysfunction syndrome. Fifteen patients suffering from myofascial pain dysfunction syndrome were included in this study. The patients were selected from the out patient clinic of oral and maxillofacial surgery department, Faculty of oral and dental medicine, Cairo university. All masseter and temporalis muscles were injected with 20-30 Units of BTX-A respectively and followed up for three months. Follow up assessment included on clinical measurements of maximal inter-incisal opening, range of lateral movement and visual analogue scale for pain. EMG images were ordered pre-operatively and at the end of 3 months period to quantify any changes in muscle activity. Results of the present study showed clinical disappearance of pain in all patients upon completing the follow up period
530			_aIssued also as CD
653		4	_aBotulinum toxin injection
653		4	_aMaxillofacial surgery
653		4	_aMyofascial pain dysfunction
700	0		_aAmany Hussein Nemat , _eSupervisor
700	0		_aMohamed Faramawy , _eSupervisor
700	0		_aSayed Mahmoud Attia , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c59883 _d59883